Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.4010
+0.0440 (12.32%)
Feb 24, 2026, 4:00 PM EST
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $5.1 million as of February 26, 2026. Its market cap has increased by 17.28% in one year.
Market Cap
5.10M
Enterprise Value
6.71M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.40
Market Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 5.10M, an increase of 202.28%. That is a compound annual growth rate of 22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 5.10M | 126.26% |
| Dec 31, 2025 | 2.25M | -55.65% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Burzynski Research Institute | 3.42M |
| ProtoKinetix | 3.19M |
| Clearside Biomedical | 2.98M |
| Vaccinex | 2.76M |
| Enzolytics | 2.42M |
| Galera Therapeutics | 2.41M |
| VitaSpring Biomedical | 2.30M |
| ZyVersa Therapeutics | 2.10M |